Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using triptorelin and flutamide may fight cancer by reducing the production of androgens. It is not yet known whether giving hormone therapy for 4 months is more effective than giving therapy for 8 months prior to radiation therapy for prostate cancer. PURPOSE: Randomized phase III trial to study the effectiveness of combination hormone therapy for 4 or 8 months followed by radiation therapy in treating patients with prostate cancer.
Epistemonikos ID: f5fc72648932ffe95f972751c1b73885b3b68d4f
First added on: May 03, 2024